Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OCGN | Common Stock | Tax liability | -$27.2K | -41.6K | -10.64% | $0.65 | 350K | Jan 3, 2024 | Direct |
Chief Scientific Officer, Head of Research, Development and Medical